ZEISS CIRRUS PathFinder1 utilises proprietary deep learning algorithms to automatically identify abnormal macular OCT B-scans as a licensed feature of a new CIRRUS software release...
This collaboration integrates RADPAIR's AI engine directly into the AdvaPACS platform...
Room State transforms surgical communication by replacing unreliable human-driven updates with AI-powered, event-driven notifications that eliminate delays and missed messages...
Projects 5X Revenue Growth by 2028, Accelerates Global Market Leadership and Paves the Way for IPO...
AI-powered solution will improve workflow, accuracy, and confidence in breast cancer detection...
DTSS's acoustic innovation addresses the healthcare application market projected to exceed $100 billion in China and approach $90 billion globally by 2030...
This clearance opens the door for SmartAlpha to launch its technology to the U.S. healthcare market at a time when AI's role in medicine is more relevant than ever...
MI Cancer Seek is the first and only test to combine whole exome sequencing (WES) and whole transcriptome sequencing (WTS) with FDA-approved CDx indications...
Expansion of facilities in Pennsylvania and Minnesota aims to boost production of AI-enabled ultrasound and image-guided therapy solutions, creating over 270 new jobs....
Survey reveals tech adoption gap despite industry focus on trial efficiency ...
